Катастрофический антифосфолипидный синдром у молодой больной системной красной волчанкой

В статье приводятся сведения о КАФС, в том числе основные концепции патогенеза, клинические проявления, морфологические особенности, подходы к диагностике и лечению, подчеркиваются его отличия от классических вариантов АФС – первичного и вторичного при СКВ. Обзор иллюстрирован клиническим наблюдением больной КАФС, развившимся как основное проявление СКВ. На примере представленного случая разбираются некоторые аспекты дифференциальной диагностики КАФС с другими микроангиопатическими синдромами – ГУС/ТТП и ДВС.

катастрофический антифосфолипидный синдром (КАФС), системная красная волчанка (СКВ), тромботическая тромбоцитопеническая пурпура, тромботическая микроангиопатия, ДВС-синдром, полиорганная недостаточность, catastrophic antiphospholipid syndrome (CAPS), systemic lupus erythematosus (SLE), thrombotic thrombocytopenic purpura, trombotic microangiopathies, disseminated intravascular coagulation syndrome

1. Тареева И.Е., Янушкевич Т.Н., Шилов Е.М., Милованов Ю.С., Романова М.Д. Быстропрогрессирующий волчаночный нефрит.// Терапевтический архив. 1990. № 6. С. 46-49.

2. Amital H, Levy Y, Davidson D et al. Catastrophic antiphospholipid syndrome: remission following leg amputation in 2 cases. //Semin Arthritis Rheum. 2001.Vol. 31.P.127-132.

3. Appel G.B., Pirani C.L., D´Agati V. Renal vascular complications of systemic lupus erythematosus.// J Am Soc Nephrol.1994.Vol. 4.P.1499-1515.

4. Asherson RA. The catastrophic antiphospholipid syndrome. //J Rheumatol.1992. Vol.19. P.508-512.

5. Asherson RA. The catastrophic antiphospholipid syndrome, 1998. A review of the clinical features, possible pathogenesis and treatment.// Lupus. 1998. Vol. 7. P. S55-S62.

6. Asherson RA, Cervera R. Catastrophic antiphospholipid syndrome. //Curr Opin Hematol. 2000.Vol. 7. P. 325-329.

7. Asherson RA, Shoenfeld Y. The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome – molecular mimicry? //J Rhematol. 2000. Vol. 27. P. 12-14.

8. Asherson RA, Cervera R., Piette J-C. et al. Catastrophic antiphospholipid syndrome. Clues to the pathogenesis from a series of 80 patients. //Medicine. 2001. Vol. 80. P. 355-377.

9. Asherson RA, Espinosa G, Cervera R, et al. Catastrophic antiphospholipid syndrome. Proposed guidelines for diagnosis and treatment. //J Clin Rheumatol. 2002. Vol. 8. P. 157-165.

10. Asherson RA, Cervera R, de Groot P et al. Catastrophic antiphospholipid syndrome (CAPS): International consensus statement on classification criteria and treatment guidelines.// Lupus. 2003. Vol. 12.P. 530-534.

11. Asherson RA. Acute respiratory distress syndrome and other unusual manifestations of the catastrophic antiphospholipid (Asherson's) syndrome.// IMAJ 2004.Vol. 6. P. 360-363.

12. Asherson RA, Espinosa G, Cervera R, et al. Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics in 23 patients. //Ann Rheum Dis. 2005. Vol.64.P. 943-946.

13. Asherson RA, Espinosa G, Menahen S et al. Relapsing catastrophic antiphospholipid syndrome: report of three cases. //Semin Arthritis Rheum. 2008; Vol. 37. P. 366-372.

14. Banfi G., Bertani T., Boery V. et al. Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. //Am J Kidney Dis. 1991. Vol. 18. P. 240-248.

15. Bayraktar U, Erkan D, Bucciarelli S et al. The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus. // J Rheumatol. 2007.Vol.34. P. 346-352.

16. Blake JS, Butani L. Rapidly progressive lupus glomerulonephritis and concomitant microangiopathy in an adolescent. //Lupus.2002. Vol.11. P. 533-535.

17. Bone RC. Why new definitions of sepsis and organ failure are needed? // Am J Med. 1993. Vol.95. P. 348.

18. Brealy D, Singer M. Multi-organ dysfunction in the critically ill: effects on different organs. //R Coll Phys. London. 2000. Vol.34. P. 428-436.

19. Bridoux F., Vrtovsnik F., Noel Ch. et al. Renal thrombotic microangiopathy in systemic lupus erythematosus: clinical correlations and long-term renal survival.// Nephrol Dial. Transplant. 1998. Vol. 13. P. 298 – 304

20. Bucciarelli S, Espinosa G, Asherson RA, et al. The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients.// Ann Rheum Dis. 2006.Vol.65. P. 81-86.

21. Bucciarelli S, Espinosa G, Cervera R et al. Mortality in the catastrophic antiphospholipid syndrome. Causes of death and prognostic factors in a series of 250 patients.// Arthritis Rheum. 2006. Vol. 54(8). P. 2568-2576.

22. Bucciarelli S, Espinosa G, Cervera R. The CAPS Registry: morbidity and mortality of the catastrophic antiphospholipid syndrome. //Lupus. 2009.Vol. 18(10). P. 905-912.

23. Cappell MS. Esophageal necrosis and perforation associated with the anticardiolipin antibody syndrome.// Am J Gastroenterol.1994. Vol.89. P. 1241-1245.

24. Cerveny KC, Sawitzke AD. Relapsing catastrophic antiphospholipid antibody syndrome: a mimic for thrombotic thrombocytopenic purpura?// Lupus.1999. Vol.8. P. 477-481.

25. Cervera R, Font J, Gomez-Puerta JA et al. Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. //Ann Rheum Dis. 2005. Vol. 64. P. 1205-1209.

26. Cervera R, Espinosa G., Cordero A. et al. Intestinal involvement secondary to the antiphospholipid syndrome (APS): clinical and immunologic characteristics of 97 patients: comparison of classic and catastrophic APS. //Semin Arthritis Rheum. 2007. Vol.36. P. 287-296.

27. Cervera R., Bucciarelli S., Plasin MA et al. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the “CAPS Registry” // Journal Autoimmun.2009. Vol. 32(3-4). P. 240-245.

28. Cohen J. The immunopathogenesis of sepsis.// Nature 2002. Vol. 420. P. 885-891.

29. Descombes E., Droz D., Drouet L. et al. Renal vascular lesions in lupus nephritis.// Medicine. 1997. Vol.76. P. 355-368

30. Dessailloud R, Papo T, Vaneecloo S et al. Acalculous ischemic gall bladder necrosis in the catastrophic antiphospholipid syndrome. //Arthritis Rheum.1998. Vol.41. P. 1318-1320.

31. Drencard C, Sanchez-Guerrero J, Alarcon-Segovia D. Fall in antiphospholipid antibody at the time of thromboocclusive episodes in systemic lupus erythematosus.// J Rheumatol. 1989. Vol. 16. P. 614-617.

32. Erkan D, Asherson RA, Espinosa G. et al. Long term outcome of catastrophic antiphospholipid syndrome survivors. //Ann Rheum Dis. 2003. Vol. 62. P. 530-533.

33. Ercan D, Cervera R, Asherson RA. Сatastrophic antiphospholipid syndrome. Where do we stand? //Arthritis Rheum. 2003. Vol. 48. P. 3320-3327.

34. Erre GL, Pardini S, Faedda R, Passiu G. Effect of rituximab on clinical and laboratory features of antiphospholipid syndrome: a case report and a review of literature.// Lupus. 2008. Vol.17:.P. 50-55.

35. Espinosa G, Cervera R, Font J, Asherson RA. The lung in the antiphospholipid syndrome.// Ann Rheum Dis.2002.Vol. 61. P. 195-198.

36. Espinоsa G, Cervera R., Asherson RA. Catastrophic antiphospholipid syndrome and sepsis. A common link? //J Rheumatol. 2007. Vol. 34(5). P.923-926.

37. Espinosa G., Cervera R. Antiphospholipid syndrome. //Arthritis Res Therapy. 2008. Vol.10. P. 230-238.

38. Fakhouri F, Vernant JP, Veyradier A et al. Efficiency of curative and prophylactic treatment with rituximab in ADAMTS 13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases. //Blood.2005. Vol. 106. P. 1932-1937.

39. Garcia-Carrasco M, Escarcega RO, Mendoza-Pinto C et al. Preventing death in the catastrophic antiphospholipid (Ascherson) syndrome. //IMAJ. 2007. Vol.9 P. 628-629.

40. Greisman S.G., Thayaparan R.S., Godwin TA.et al. Occlusive vasculopathy in systemic lupus erythematosus − association with anticardiolipin antibody. //Arch Intern Med. 1991.Vol.151. P. 389-392.

41. Griffiths M.H., Papadaki L., Neild G.H. The renal pathology of primary antiphospholipid syndrome: a distinctive form of endothelial injury. Quart. //J. Med. 2000. Vol. 93. P. 457-467.

42. Gunnewiek J.M, Van Der Hoeven J.C. Cardiac troponin elevations among critically ill patients.// Curr Opin Crit Care. 2004.Vol.10. P. 342-346.

43. Ingram S.B., Goodnight S.H, Bennet R.M. An unusual syndrome of a devastating non-inflammatory vasculopathy associated with anticardiolipin antibodies: a report of two cases. //Artritis Rheum. 1987. Vol. 30. P. 1167-1172.

44. Jurgensen J.S, Kettritz R., Schneider W. et al. Catastrophic antiphospholipid syndrome masquerading as ischemic colitis.// Rheumatol Int. 2003. Vol. 23. P. 204-206.

45. Kitchens C.S. Thrombotic storm: when thrombosis begets thrombosis. //Am J Med. 1998.Vol.104. P. 381-385.

46. Kwok S.K, Ju J.H, Cho C.S. at al. Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: risk factors and clinical outcome: a single centre study.// Lupus. 2009. Vol. 18. P.16-21.

47. Laterza O.F, Nayer H., Jo Bill M. et al. Unusually high concentration of cTnI and cTnT in a patient with catastrophic antiphospholipid antibody syndrome.// Clin Chim Acta. 2003. Vol. 337 P. 173-176.

48. Levy M.M, Fink M.P, Marshall J.C et al. SCCM/ESICM/ACCPATS/SIS International Sepsis Definitions Conference. // Crit Care Med. 2003. Vol.31. P. 1250-1256.

49. Manadan A.M, Harris C, Schwartz M.M. The frequency of thrombotic thrombocytopenic purpura in patients with systemic lupus erythematosus undergoing kidney biopsy. //J Rheumatol. 2003.Vol. 30.P. 1227-1230.

50. Meroni P.L, Raschi E, Camera G.et al. Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestation of the syndrome.// J Autoimmun. 2000. Vol. 15. P. 237-240.

51. Mizuno R., Fujimoto S., Fujimoto T.et al. Catastrophic antiphospholipid antibody syndrome in systemic lupus erythematosus: an autopsy case report of a young woman. //Internal Medicine. 2000. Vol. 39. P. 856-859.

52. Olguin-Ortega L, Jara L.J, Becerra M. et al. Neurological involvement as a poor prognostic factor in catastrophic antiphospholipid syndrome: autopsy finding in 12 cases.// Lupus.2003. Vol.12.P. 93-98.

53. Pierangelli S.S, Vega-Ostertag M.E, Raschi E. et al. Toll-like receptor and antiphospholipid thrombosis: in vivo studies. //Ann Rheum Dis. 2007. Vol. 66. P. 1327-1333.

54. Rojas-Rodriguez J, Garcia-Carrasco M, Ramos-Casals M et al. Catastrophic antiphospholipid syndrome. Clinical description and triggering factors in eight patients.// J Rheumatol. 2000. Vol.27. P. 238-240.

55. Rottem M., Krause I., Fraser A. et al. Autoummune hemolytic anaemia in the antiphospholipid syndrome. //Lupus 2006. Vol.15. P. 473-477.

56. Rubenstein E., Arkfeld D., Metyas S. et al. Rituximab treatment for resistant antiphospholipid syndrome.// J Rheumatol. 2006. Vol.33. P. 355-357.

57. Schwartz M.M. Lupus vasculatis. //Contrib.Nephrol. 1992. Vol.99. P. 35-45.

58. Tektonidou M.G, Sotsiou F, Moutsopoulos H.M. Antiphospholipid syndrome (APS) nephropathy in catastrophic, primary and systemic lupus erythematosus-related APS. //J Rheumatol. 2008. Vol.35. P.1983-1988.

59. Uthman I, Khamashta M. The abdominal manifestations of the antiphospholipid syndrome. //Rheumatology.2007.Vol. 46. P. 1641-1647.

60. Vora S.K, Asherson R.A, Ercan D. Catastrophic antiphospholipid syndrome.// J Intensive Care Med. 2006. Vol. 21. P. 144-159.

61. Wiedermann F.J., Mayr A., Schobersberger W. et al. Acute respiratory failure associated with catastrophic antiphospholipid syndrome.// J Intern Med. 2000. Vol.247. P. 723-730.

62. Yamamoto H., Iwade T., Nakano R. et al. Numerous small vegetations revealing Libman-Sacks endocarditis in catastrophic antiphospholipid syndrome.// Circulation.2007. Vol.116.Р.531-535.

63. Yu F., Tan Y., Zhao M-H. Lupus nephritis combined with renal injury due to thrombotic thrombocytopaenic purpura-haemolytic uraemic syndrome. //Nephrol Dial Transplant. 2010. Vol.25.P. 145-152.